<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01444222</url>
  </required_header>
  <id_info>
    <org_study_id>s53471</org_study_id>
    <nct_id>NCT01444222</nct_id>
  </id_info>
  <brief_title>Behaviour of Tricuspid Valve Regurgitation in Volume and/or Pressure Loaded Right Heart</brief_title>
  <official_title>Behaviour of Tricuspid Valve Regurgitation in Volume and/or Pressure Loaded Right Heart</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pieter De Meester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Right-sided heart disease has an important impact on the prognosis of patients with valvular
      heart disease. Up to now, Tricuspid Valve Regurgitation (TR) and right heart hemodynamics
      have not been extensively investigated. However, it is plausible that a significant degree of
      TR and the associated volume-overload of the right ventricle cause significant right
      ventricular wall stress. Although minor TR generally is well tolerated, major TR can lead to
      clinical symptoms, right ventricular dilatation and ultimately right ventricular heart
      failure. Up to now, the investigators do not dispose of any tools to diagnose and anticipate
      this unfavourable evolution. Nevertheless it is likely that right ventricular failure is
      preceded with a subclinical dysfunction of the right ventricle and a possibly reversible
      change in contractility of the myocardium.

      Recently, new techniques to evaluate the systolic function, the contractility and the
      hemodynamics of the heart have become available.

      First, this study will help us assessing the feasibility and accuracy of several imaging
      modalities in right-sided heart pathology with focus on TR and right heart myocardial
      performance.

      Second, this study will contribute to a better understanding of the hemodynamic effect of
      volume-overload and/or pressure-overload of the right ventricle. It will clarify the
      behaviour of TR, the evolution of right ventricular myocardial contractility and dysfunction
      during exercise and its impact on exercise capacity. By doing this, discrimination between
      well tolerated and ill-tolerated TR will be possible, thus identifying patients who might be
      eligible for treatment (medical, corrective, â€¦).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2011</start_date>
  <completion_date type="Anticipated">August 2012</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <number_of_groups>8</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Tricuspid Valve Insufficiency</condition>
  <arm_group>
    <arm_group_label>Pulmonary Hypertension</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>pulmonic valve stenosis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>pulmonic valve homograft</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>pulmonic valve insufficiency</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>atrial septum defect</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Ebstein's anomaly</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>transvalvular right ventricular lead</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        -  Pulmonary Arterial Hypertension

          -  Pulmonic Valve Stenosis

          -  Pulmonic valve insufficiency

          -  Atrium Septum Defect

          -  Ebstein's Anomaly

          -  Transvalvular RV pacemaker/ shock lead

          -  Control
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pulmonary Arterial Hypertension

          -  Pulmonic Valve Stenosis

          -  Pulmonic valve homograft

          -  Pulmonic valve insufficiency

          -  Atrium Septum Defect

          -  Ebstein's Anomaly

          -  Transvalvular RV pacemaker/ shock lead

          -  Control

        Exclusion Criteria:

          -  age &lt; 16 years

          -  not fit for bicycle testing
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Werner Budts, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitaire Ziekenhuizen Leuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pieter De Meester, MD</last_name>
    <phone>016342371</phone>
    <phone_ext>0032</phone_ext>
    <email>pieter.demeester@uzleuven.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>UZLeuven</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams-Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pieter De Meester, MD</last_name>
      <phone>016342371</phone>
      <phone_ext>0032</phone_ext>
      <email>pieter.demeester@uzleuven.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>September 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 27, 2011</study_first_submitted>
  <study_first_submitted_qc>September 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2011</study_first_posted>
  <last_update_submitted>September 30, 2011</last_update_submitted>
  <last_update_submitted_qc>September 30, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 3, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Universitaire Ziekenhuizen Leuven</investigator_affiliation>
    <investigator_full_name>Pieter De Meester</investigator_full_name>
    <investigator_title>research fellow</investigator_title>
  </responsible_party>
  <keyword>Myocardial contractility</keyword>
  <keyword>Quantification of regurgitant flow</keyword>
  <keyword>exercise capacity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tricuspid Valve Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

